The performance of the NHS has come under the spotlight once again, following figures showing worst-ever performances against waiting times targets for cancer treatment and in A&E.
Bristol-Myers Squibb’s (BMS) chief scientific officer Francis Cuss is to step down following the company's huge lung cancer setback with Opdivo last year, to be replaced by former Massachus
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
